Breast Cancer Therapy
Study results from Massachusetts General Hospital update understanding of breast cancer therapy
Published in Women's Health Weekly, February 7th, 2008
New investigation results, 'Application of aromatase inhibitors in endocrine responsive breast cancers,' are detailed in a study published in The Breast. According to recent research from the United States, "Aromatase (estrogen synthetase) inhibitors (AIs) have been incorporated into adjuvant treatment of early-stage breast cancer in post-menopausal women and their role in pre-menopausal is being investigated. Several questions regarding AIs remain unanswered: optimal sequence with tamoxifen; optimal duration and the best agent in the class."
"The benefits of extending therapy beyond 5 years has been established by the MA17 trial and many follow-on trials are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Arthritis
Osteoarthritis risk linked to finger length ratio - Arthritis
Why some depressed girls can't smell the roses - Inderscience Publishers
Skull survey could improve vehicle safety - Lupus
Genes linked with lupus are revealed, giving hope for new treatments - Lupus
Lupus in women: New genetic risk factors identified - Menopause
Walk away menopausal anxiety, stress and depression - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
